Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S‐ketamine
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background:Oral ketamine is used as an adjuvant in the treatment of refractory neuropathic and cancer‐related pain. Drug interactions may alter the analgesic or other effects of ketamine. Aim and methods:The aim of the study was to investigate the effect of cytochrome P450 3A enzyme inhibition with clarithromycin on the pharmacokinetics and pharmacodynamics of oral S‐ketamine in a randomized controlled cross‐over study with two phases. Ten healthy subjects were pre‐treated with oral clarithromycin or placebo for 4 days. On day 4, they ingested an oral dose of 0.2 mg/kg of S‐ketamine syrup. Plasma concentrations of ketamine and norketamine were measured for 24 h. Analgesic effects were evaluated in a cold pressor test and psychomotor effects were followed for 12 h. Results:Clarithromycin increased the mean Cmax of ketamine by 3.6‐fold (p< 0.001) and the mean AUC 0–∞of ketamine by 2.6‐fold (p= 0.001). The relative amount of the CYP3A dependent metabolite norketamine was decreased by 54% by clarithromycin (p= 0.004). Self‐rated drug effect of S‐ketamine was enhanced by clarithromycin (p< 0.05) but other behavioral effects or cold pain scores were not affected. Conclusions:Clarithromycin strongly increases plasma concentrations of oral S‐ketamine probably by inhibiting its CYP3A‐mediated N‐demethylation. This increase is reflected as modest changes in behavioral effects of oral S‐ketamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans
Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710516 · Cited by 420 · cited 2×
“After oral administration, peak plasma concentrations (Cmax) are reached in approximately 30 min (Grant et al., 1981; Clements et al., 1982; Yanagihara et al., 2003).”
Background
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
Self-citationKetamine for chronic pain: risks and benefits
Niesters, M., Martini, C., & Dahan, A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12094 · Cited by 508
Role of Cytochrome P4502B6 Polymorphisms in Ketamine Metabolism and Clearance
Rao, L. K., Flaker, A. M., Friedel, C. C., & Kharasch, E. D. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001392 · Cited by 67
Bolhuis, M. S., Panday, P. N., Pranger, A. D., Kosterink, J. G. W., & Alffenaar, J.-W. C. (2011) · Pharmaceutics · doi:10.3390/pharmaceutics3040865 · Cited by 62
Metadata
- Authors
- Hagelberg, N. M., Peltoniemi, M. A., Saari, T. I., Kurkinen, K. J., Laine, K., Neuvonen, P. J., & Olkkola, K. T.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2010-07
- Volume
- 14
- Issue
- 6
- Pages
- 625-629
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2135645785
- Cited by
- 55
- References
- 2
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S‐ketamine. https://app.cochat.ai/papers/10.1016/j.ejpain.2009.10.003
- The paper
- Hagelberg, N. M., Peltoniemi, M. A., Saari, T. I., Kurkinen, K. J., Laine, K., Neuvonen, P. J., & Olkkola, K. T. (2010). Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S‐ketamine. European Journal of Pain. https://doi.org/10.1016/j.ejpain.2009.10.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.